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Abstract  
Introduction: Positive HIV results disclosure plays a significant role in the successful prevention and care of HIV infected patients. It provides 
significant social and health benefits to the individual and the community. Non-disclosure is one of the contextual factors driving the HIV epidemic 
in Uganda. Study objectives: to determine the frequency of HIV disclosure, associated factors and disclosure outcomes among HIV positive 
pregnant women at Mbarara Hospital, southwestern Uganda. Methods: A cross-sectional study using quantitative and qualitative methods among 
a group of HIV positive pregnant women attending antenatal clinic was done and consecutive sampling conducted. Results: The total participant 
recruitment was 103, of which 88 (85.4%) had disclosed their serostatus with 57% disclosure to their partners. About 80% had disclosed within 
less than 2 months of testing HIV positive. Reasons for disclosure included their partners having disclosed to them (27.3%), caring partners 
(27.3%) and encouragement by health workers (25.0%). Following disclosure, 74%) were comforted and 6.8% were verbally abused. Reasons for 
non-disclosure were fear of abandonment (33.3%), being beaten (33.3%) and loss of financial and emotional support (13.3%). The factors 
associated with disclosure were age 26-35 years (OR 3.9, 95% CI 1.03-15.16), primary education (OR 3.53, 95%CI 1.10-11.307) and urban 
dwelling (OR 4.22, 95% CI 1.27-14.01). Conclusion: Participants disclosed mainly to their partners and were comforted and many of them were 
encouraged by the health workers. There is need to optimize disclosure merits to enable increased participation in treatment and support 
programs. 
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Introduction 
 
HIV/AIDS remains a major public health problem and more effort is 
needed to ensure successful treatment and prevention programs. 
Disclosure is an important component in uptake of prevention of 
mother-to-child transmission (PMTCT) services [1]. Women are 
counseled to share with their partner their own HIV test result and 
they become responsible for encouraging their partner to undertake 
HIV testing. The dialogue on sexual activity or HIV/AIDS within a 
couple is often difficult, especially when women discover that they 
are HIV-infected [2]. Among postpartum mothers, disclosure is 
associated with adherence to safer infant feeding practices, 
exclusive breast feeding, exclusive replacement feeding, creates 
awareness about HIV risk for the untested sexual partners, supports 
risk reduction, promotes safer sexual behavior, increased retention 
in eMTCT programs, leads to better clinical outcomes such as CD4+ 
count increases and higher rates of retention in treatment programs 
[3-12]. Studies also show that disclosure is a potential strategy for 
dealing with stigma among patients receiving antiretroviral therapy 
[13]. Despite these potential benefits, studies indicate the frequency 
of non-disclosure remains relatively high. About 25% of HIV 
infected patients do not disclose their HIV serostatus to their 
partners [14]. The proportion of women disclosing their HIV 
serostatus to their partners among HIV positive pregnant women 
attending antenatal care is even larger (60%) [15]. Disclosure is a 
complex process that requires delicate handling to prevent 
occurrence of unwanted effects [16]. HIV status disclosure can be a 
period of heightened risk for partner stigma, abuse and financial 
withdrawal and thus should be handled with caution [17, 18]. 
Therefore, the purpose of this study was to determine the 
frequency, factors associated with disclosure and the potential 
barriers and facilitators to disclosure of HIV serostatus by pregnant 
women attending antenatal clinic at Mbarara Regional Referral 





Study site: The study was conducted at Mbarara Regional Referral 
Hospital Antenatal Care clinic (ANC). The study was conducted 
among HIV positive pregnant women attending the antenatal clinic 
at Mbarara Regional Referral Hospital ANC. The antenatal clinic sees 
700 women per month at least 90% of women in Uganda attend at 
least one antenatal visit during their pregnancy. The antenatal HIV 
prevalence in Uganda is 6.4% while the prevalence in Mbarara 
Hospital maternity ward is about 12% [19]. Mbarara Hospital is both 
a teaching hospital for Mbarara University Medical School and 
Regional Referral Hospital located within Mbarara Municipality, 
Mbarara district in the Western region of Uganda about 270Km from 
the capital city Kampala. The facility provides care for a diverse 
ethnic group of patients from the region, including some parts of 
the Democratic Republic of Congo, Rwanda and the Northern part of 
Tanzania. 
  
Study design: The study was a cross sectional study using both 
quantitative and qualitative methods. The quantitative method 
involved use of interviewer-administered pre-tested questionnaires 
while the qualitative method involved two focus group discussions 
(FGDs) i.e. eight HIV positive women who had disclosed their 
serostatus and eight positive women who had not disclosed. 
  
Sample size and sampling procedure: The sample size 
calculated was 103 women using the formula by Kish and Leslie 
(1965). The sample size was calculated based on the assumption 
that 20% of women attending antenatal clinic will not disclose HIV 
results to anyone. Using an error margin of 7.5%, an estimated 103 
women were sufficient to answer the study objectives. The HIV 
positive pregnant women attending MRRH ANC were consecutively 
recruited until the desired number of 103 was achieved while every 
5th respondent during the quantitative survey was also requested to 
participate in a focus group discussion until the required number of 
eight participants per group. 
  
Data collection and instruments: The HIV positive mothers 
were received at the registration desk with the rest of the pregnant 
women. They were identified using the HIV status codes on their 
ANC charts. The clinician handed them over to a research assistant 
in a separate room away from the routine antenatal clinic activities. 
The research assistant provided the mothers with information about 
the study and sought their consent to participate. Quantitative data 
was collected using interviewer-administered pre-coded pre-tested 
questionnaires to determine: The socio-demographic variables such 
as age, marital status, residence, employment, education level, 
nature of domicile, religion, parity and tribe. The disclosure status 
(disclosed or not disclosed), to whom, when it was done, and the 
outcomes of disclosure were collected. The questionnaire was pre-
tested and translation double verified. The questionnaire was 
piloted, and necessary adjustments made. The data was cleaned. 
Page number not for citation purposes 3 
During the focus group discussions, the interview was recorded 
using a voice recorder. 
  
Data entry and analysis: Quantitative data was entered into the 
EPI-INFO program and analyzed using the statistical package for 
social science (SPSS version 12). The categorical data was 
summarized into frequencies or proportions. The socio-demographic 
characteristics of women who disclosed their HIV serostatus were 
analyzed. The primary outcome for the quantitative analysis was 
disclosure. The association between social, economic and 
demographic categorical variables with disclosure status was 
obtained using binary logistic regression analysis and an association 
was considered significant if the p-value was less than 0.05. The 
qualitative data was verbatim transcripted, categories created with 
evidences from the responses and coded using the thematic content 
analysis. 
  
Ethical consideration: The work was presented to the 
department of obstetrics and Gynecology at Mbarara University and 
ethical approval sought from the faculty research ethical committee. 
Individual consent was obtained from the participants enrolled. Only 
participants who voluntarily agreed to participate in the study 





Majority of the participants were between the ages of 18 and 35 
years (94.2%), Christians (89.3%), had primary education (56.3%), 
were married either monogamously or polygamously (94.1%), were 
multipara (61.2%), lived in a nuclear family setting (71.8%), 
unemployed (59.2%) and had a monthly income of between 
50,000-100,000 Uganda shillings (42.7%). Among the respondents 
who were below 18 years, 83.3% had disclosed their serostatus. 
Disclosed among those who had no formal education was 100% 
(Table 1). Persons disclosed to included partners (57%), parents 
(25%), friends (9%), relatives (6%) and siblings (3%). Out of the 
103 respondents, 88 (85.4%) had disclosed to at least someone. 
About seventy nine percent (79%) had disclosed within less than 2 
months of testing positive while 9.1% had disclosed after 6 or more 
months of having tested positive (Table 2). One of the respondents 
in the focus group discussions reported having disclosed within 
seven days as evidenced by her response i.e. "I told my husband on 
the second day following my testing positive because he had 
disclosed to me his serostatus and was openly taking his HIV 
drugs" said 30-year-old mother of three. Most women who disclosed 
their sero-status were encouraged by health care workers, had 
partners who were caring and had disclosed to them (Table 3). This 
was further supported by information gathered from the focus 
group discussions where participants reportedly disclosed because 
their partners had disclosed to them and some had been 
encouraged to do so by the health workers as said by participants a 
32-year mother of four children and 22 year a primipara 
respectively: "I told my husband on the second day following my 
testing positive because he had disclosed to me his serostatus and 
was openly taking his HIV drugs". "The health worker always 
reminded and encouraged me whenever we met and I got the 
boldness to tell my husband" 
  
Reasons for non-disclosure: included fear of abandonment 
(32%), being beaten (32%), loss of financial support (12%), 
stigmatization (12%), loss of emotional support (6.7%) and others 
thought that disclosure was not necessary (6.7%). The above 
information from the questionnaires was supported by information 
gathered from the focus group discussions where women reported 
fear of death, divorce, being beaten, job denial and ignorance of the 
importance of disclosure were reported as some of the barriers to 
disclosure. Some of the responses included the following 
i.e. "Knowing that he easily gets upset by small things and begins 
fighting, if I tell him about my status will he not beat me to death? 
His brother beat his wife seriously when he found that she was 
positive, and he is now in prison" said 29-year old primary school 
teacher. "Can't I live with my disease without bothering people by 
telling them of my issues? In feel comfortable that way" reported a 
40-year-old prisons warder and a mother of 6 children. "I am 
looking for a job right now and if probable employers get to know 
that am positive, they may deny me a job. I will reveal my status 
when I have a job" reported a 34-year-old mother of 3 children. 
  
Post disclosure experiences: Majority of the women who 
disclosed were comforted (73.9%). However, negative outcomes 
included accusation of infidelity (24.9%), others were verbally 
abused (6.8%), some were beaten (5.7%) and a few were chased 
out of their homes by their husbands and the relatives of their 
husbands (2.3%). The information from the focus group discussions 
lent further credence to that gathered from the questionnaires with 
respondents reporting increased support and comforting as said by 
a 25-year old mother of 3: "When I told my mother that I was HIV 
positive, she was so sad but later comforted me and promised to 
Page number not for citation purposes 4 
give me all the support I needed". She had also told her partner "My 
partner pledged his support and continued love till death do us part. 
He has always reminded me to take my drugs and goes with me to 
hospital during my clinic days". Negative, some mothers reported 
financial loss, being beaten, denial of conjugal rights, divorce and 
stigma as some of the outcomes of their having disclosed their 
serostatus. Some of their responses included the following 
i.e. "When I told my partner, he beat me that night and locked me 
in the house for two days though he came back to his senses and 
stopped harassing me" reported 18-year-old primipara. 
  
Factors associated with disclosure: The factors associated with 
disclosure were age between 26-35 years. This age group has 3.9-
fold increase in the odds of disclosure compared to those in the 18-
25 year age category (OR 3.9, 95% CI 1.03-15.16). Primary 
education was associated with a 3.5-fold increase in the odds of 
disclosure (OR 3.53, 95% CI 1.10-11.307) compared to those with 
post primary education. Urban dwelling was associated with an over 
4-fold increase in the odds of disclosure compared to the rural folk 





About 85% of the participants had disclosed their HIV serostatus to 
at least one person and of these participants, 57% had disclosed to 
their partners. Almost 80% had disclosed within less than 2 months 
of testing HIV positive. Women disclosed their serostatus because 
their partners had disclosed to them (27.3%), their partners were 
caring (27.3%) and health workers had encouraged them to 
disclose (25.0%). Following disclosure, majority were comforted 
(73.9%) while others (6.8 %) were verbally abused. Those who did 
not disclose feared abandonment (33.3%), being beaten (33.3%) 
and loss of financial and emotional support (13.3%). The factors 
associated with disclosure included age group 26-35 years, primary 
education level and urban residence. A study in Dar Es salaam, 
Tanzania in an ANC clinic interviewing HIV positive women about 
disclosure to their partners found that 69% had disclosed to their 
partners [20]. The overall HIV status disclosure to sexual partner in 
a study in Ethiopia was 57.4% and the study showed that there is 
significant association between knowing HIV status of the sexual 
partner [21]. The rate of disclosure to partners in our study was 
57%. These rates of disclosure to partners are almost similar 
probably because the settings were almost the same and the 
populations studied were from the low resource settings and had 
similar socio-economic and demographic characteristics. 
  
Negative disclosure outcomes and reasons for non-
disclosure: in our study, women who disclosed were accused of 
infidelity, others were verbally abused, beaten, and a few were 
chased out their homes by their husbands and the relatives of their 
husbands. The women feared abandonment, being beaten, loss of 
financial support, stigmatization, loss of emotional support and 
others did not know the importance of disclosure. The three 
commonest reasons for non-disclosure in other studies are fear 
regarding spread of the information, stigmatization and 
deterioration in the relationship with the spouse [22]. This could be 
because this group of women considered the disclosure process to 
be too difficult and risky to undertake and engaged in avoidant 
behaviors to hide their HIV status. Women who do not disclose their 
HIV status to their sexual partners sometimes do not practice safer 
sex, especially condom use and it is possible that this group of 
women may be more likely to have re-infection [23]. The negative 
outcomes may lead women to choose not to share their HIV test 
results with their friends, family and sexual partners. This, in turn, 
leads to lost opportunities for the prevention of new infections and 
for the ability of these women to access appropriate treatment, care 
and support services where they are available. 
  
Positive disclosure outcomes: Most women who disclosed their 
HIV serostatus in our study were comforted and now able to 
participate in HIV treatment programs. Disclosure of HIV status 
expands the awareness of HIV risk to untested partners, which can 
lead to greater uptake of voluntary HIV testing and counseling and 
changes in HIV risk behaviors. In addition, disclosure of HIV status 
to sexual partners enables couples to make informed reproductive 
health choices that may ultimately lower the number of unintended 
pregnancies among HIV-positive women [9]. Among women, who 
disclose their HIV serostatus to their families, friends and sex 
partners, the incidence of regret is minimal and that disclosure 
improved on relationship satisfaction and security [24]. Disclosure is 
necessary to initiate discussions about HIV/AIDS and this raises 
each partner's awareness of the risk of infection and may ultimately 
lead to behavior change to reduce risk reduction. Disclosure can be 
an important starting point for HIV positive women to begin 
discussing the use of contraception with their partners and reduce 
the number of unintended pregnancies among HIV infected women. 
Disclosure helps in women's uptake of PMTCT programs and in their 
participation in treatment and support programs. To benefit from 
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interventions that can reduce HIV perinatal transmission, women 
who are HIV infected must be willing to accept and adhere to 
PMTCT prophylaxis. The optimal uptake and adherence to PMTCT 
programs is difficult for women whose partners are either unaware 
or not supportive of their participation. It is well documented in 
Africa that women often lack the power to make independent 
decisions about their own health care. It is therefore difficult for HIV 
infected women to seek social and medical support from care and 
treatment programs for themselves and their infants without first 
disclosing their HIV serostatus to their partners [25]. 
  
Factors associated with disclosure: In our study, the reasons 
given by the women for disclosure were partner having disclosed 
their status first, partner being caring, encouragement by the health 
worker and because they wanted to practice safer sex. The factors 
associated with disclosure included being an urban dweller and 
having age more than 25 years. This may be because of easy 
access to information and treatment opportunities compared to the 
people living in the rural areas. This could also be because those 
who are older than 25 years are more likely to have spent a longer 
time in relationships and thus built trust over time resulting into a 
higher chance to have disclosed compared to the younger ones. The 
older women are more likely to have gotten pregnant more times 
than those younger than 26 years and this could have exposed 
them to more information about disclosure leading to their being 
more likely to disclose. Disclosure is associated with being married, 
increased condom use, knowledge of partner's HIV serostatus, 
knowledge of the partner's status, late stage, staying together with 
partner, discussion about HIV testing before going for testing, 
having secondary education, age of more than 25 years, attending 
more antenatal care visits [26, 27]. Other factors associated with 
disclosure include having communication skills to disclose, having 
initiated anti-retroviral therapy, receiving ongoing counselling, 
having ever seen an HIV infected person publicly disclose their HIV 
status, being married, knowing the importance of HIV serostatus 
disclosure and being employed [28, 29]. The strength of our study 
is that it employed mixed methods to determine responses to 
multiple aspects of the disclosure are among a vulnerable group of 








There is heightened need to emphasize the importance of disclosure 
to enable increased participation in treatment and support 
programs; and find ways of minimizing the negative consequences 
and optimizing the positive outcomes of disclosure of the HIV 
status. 
 
What is known about this topic 
 That disclosure is a potential strategy for dealing with 
stigma among patients receiving antiretroviral therapy; 
 HIV status disclosure can be a period of heightened risk 
for partner stigma, abuse and financial withdrawal and 
thus should be handled with caution; 
 Disclosure is a complex process that requires delicate 
handling to prevent occurrence of unwanted effects. 
What this study adds 
 The disclosure proportions among HIV-infected pregnant 
women in Mbarara Hospital; 
 The factors associated with disclosure among HIV-
infected pregnant women in Mbarara Hospital; 
 The reasons for non-disclosure among HIV-infected 
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Disclosed n=88 (%) P-value 
Age       
Below 18 1(6.7) 5 (5.6%) 0.40 
26-35 6 (40) 43 (48.9%) 0.05 
18-25 8 (53.3) 40 (45.5%)   
Religion       
Catholic 6 (40) 32 (36.4%)   
Anglican 7 (47) 44 (50%) 0.20 
Others 2 (6.5) 12 (12.5%) 0.64 
Education level       
No formal or Primary 10 (66.7) 58 (66%) 0.03 
Post-primary 5 (33.3) 30 (33%)   
Marital Status       
Married monogamously 9 (60) 57 (64.8%) 0.26 
Married polygamously 3 (20) 27 (30.7%) 0.51 
Others (Single/Separated) 3 (20) 4 (4.5%)   
Parity       
Prime gravida 5 (33.3) 26 (29.5%)   
Multipara (2-4) 9 (60) 55 (62.5%) 0.41 
Grand multipara (5 or more) 1 (6.7) 7 (8%) 0.65 
Domicile       
Nuclear family 74 (71.8) 62 (70.5%) 0.45 
Extended family 29 (28.2) 26 (29.5%)   
Residence       
Urban 10 (66.7) 44 (50%) 0.02 
Rural 5 (33.3) 44 (50%)   
Patient employment       
Unemployed 9 (60) 53 (60.2%) 0.83 
Informal sector 4 26.7) 29 (33%) 0.38 
Formal/skilled 2 (13.3) 6 (6.8%)   
Monthly income (Uganda 
shillings) 
      
Less than 50,000 4 (26.6) 25 (28.4%)   
50,000-100,000 7 (46.7) 39 (44.3%) 0.53 
More than 100,000 4 (26.7) 24 (27.3%) 0.76 
Page number not for citation purposes 10 
 
Table 2: Frequency and timing of disclosure among women 
attending antenatal clinic at Mbarara Regional Referral 
Hospital 
Variable 
Frequency (percent %) 
N (%) 
Disclosure status   
Yes 88 (85.4) 
No 15 (14.6) 
Disclosure timing   
Less than 2months 70 (79.5) 
2-5months 10 (11.4) 




Table 3: Factors that motivated disclosure among pregnant women who 
disclosed their HIV sero-status, Mbarara Hospital, Uganda (n = 88) 
Factors motivating disclosure Frequency (percent %) 
He had disclosed to me 24 (27.3) 
He was caring 24 (27.3) 
I was financially stable 7 (8.0) 
Wanted safer sex 11 (12.5) 






Table 4: factors associated with disclosure of HIV among 
pregnant women attending antenatal clinic at Mbarara 
Regional Referral Hospital 
Variable Odds Ratio (95%CI) P-value 
Age 
  
Less than 18 2.9 (0.25-33.07) 0.40 





No formal or Primary 
education 
3.53 (1.10-11.307) 0.03 




Urban 4.22 (1.27-14.01) 0.02 
Rural 1 
 
